Modified Nucleosides
1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil
Quick view. A beta-D-threo/deoxyxylo thymine nucleoside building block for structure-specific modified-nucleoside and nucleotide research. CAS 16053-52-4. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil is classified as modified nucleosides (Formula C10H14N2O5; molecular weight 242.23).
1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil — Beta-D-threo/deoxyxylo thymine nucleoside building block for structure-specific modified-nucleoside and nucleotide research.
For 1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- 1-(2'-Deoxy-beta-D-threopentofuranosyl)thymine
- 3'-beta-Thymidine
Useful catalog search terms
- CAS 16053-52-4
- PubChem CID 72247
Physicochemical data
| PubChem CID | 72247 |
|---|---|
| InChIKey | IQFYYKKMVGJFEH-BWZBUEFSSA-N |
| IUPAC name | 1-[(2R,4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione |
| SMILES | CC1=CN(C(=O)NC1=O)[C@H]2C[C@H]([C@H](O2)CO)O |
| Sugar configuration | beta-D-threo / 2-deoxy-beta-D-xylo |
| InChI | InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16) |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosyl-L-methionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-01875-(Carboxyhydroxymethyl)uridine
Modified Nucleosides · CAS: 934743-11-0
BX-MN-0719(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine
Modified Nucleosides · CAS: 96392-15-3
BX-MN-01972,2'-Cyclocytidine hydrochloride
Modified Nucleosides · CAS: 10212-25-6
BX-MN-0199N3-Allyluridine
Modified Nucleosides · CAS: 103951-13-9
Frequently asked questions
Can the package size for 1-(2-Deoxy-beta-D-xylofuranosyl)-5-methyluracil be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0273 and CAS 16053-52-4, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
These publications provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.